Body Shortcuts
R&D JW, leading global new drug development

Research Center

Research center status
JW Sinyak has incorporated JW creagene as its subsidiary in 2009, leading the development of new immune - based treatments.
  • Sungnam-si, Gyeonggi

    JW Creagene

    Core foundation technique :
    Immune cell vaccine

    • - Dendritic cell vaccine
    • - Cytoplasmic transduction peptide technology (CTP)
    • - Protein manufacturing techniques